+$3.1M
Net Activity
Institutions Holding
44
Popularity Rank
#6307
Avg Weight
0.03%
Total Value
$7.9M
44 institutions currently hold VYNE, with 15 net buyers and 10 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
10
Net Buying Institutions
15
Top 5 by Value
+$4.5M
Total Buy Value
$2.3M
Total Sell Value
15
Net Buyers
10
Net Sellers
No Form 144 planned sale filings in the last 90 days
0
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| Zhang Xiaofan | 13G/A | 2026-07-14 | 0.0% |
2
Filings (14d)
VYNE Therapeutics Inc. made an investor presentation from Yarrow Bioscience, Inc. available on its website on July 14, 2026. The presentation, attached as Exhibit 99.1, is intended for investor relations purposes. This filing also references VYNE's proposed transaction with Yarrow and directs investors to the related S-4 registration statement for more details.
View Full Filing (SEC EDGAR)No AI summary for this filing type
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter